MARYIKA GIBSON: Open Payments
NPI 1427471275 · CAMAS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 17 payments from 5 companies in 2025. Trend: 2023 $120 · 2024 $341 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 11 | $372 |
| AstraZeneca Pharmaceuticals LP | 1 | $91 |
| UCB, Inc. | 2 | $61 |
| ABBVIE INC. | 2 | $61 |
| Boston Scientific Corporation | 1 | $44 |
Products named: XCOPRI, FARXIGA, Nayzilam, VersaCross Access Solution, QULIPTA, BOTOX.
Industry payments across WA — which companies pay providers there.
